Genmab A/S (NASDAQ:GMAB) is one of the most profitable biotech stocks to invest in now. In a report released on July 14, ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most profitable biotech stocks to invest in now. TD Cowen analyst Tyler Van ...

Bio-Techne Corporation (NASDAQ:TECH) is one of the most profitable biotech stocks to invest in now. On July 9, TD Cowen ...

United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, ...

TD Cowen has raised its price target for Strategy’s stock from $590 to $680 per share, citing the company’s deepening role as ...

CSX experienced a tough second quarter and first half of 2025, compared to the prior-year’s periods, but saw some sequential ...

In a report released today, William Katz from TD Cowen reiterated a Buy rating on Invesco, with a price target of $29.00. The company’s shares opened today at $21.55. Take advantage of TipRanks ...

Klaviyo, Inc. (NYSE:KVYO) is one of the Most Promising New Technology Stocks According to Wall Street Analysts. On June 23, ...

In addition to TD Cowen, Centene also received a Hold from Robert W. Baird’s Michael Ha in a report issued yesterday. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on Centene ...

TD Cowen defends Strategy Inc.'s Bitcoin premium, calling criticism “logically flawed.” Strategy continues buying BTC, boosting holdings and investor returns.

TORONTO and NEW YORK, March 1, 2023/ PRNewswire/- TD Bank Group and Cowen Inc. today announce that TD has completed the acquisition of Cowen. Together, with greater scale, broader capabilities and ...

TD Bank / Anthony Quintano 1. Toronto-Dominion Bank's $1.3 billion move for Cowen underscores that the Canadian lender wants more of the US investment-banking pie.The deal comes after TD agreed to ...